More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML).
about
FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitationsPhase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia.The Biology and Targeting of FLT3 in Pediatric Leukemia.Thalidomide and lenalidomide: Mechanism-based potential drug combinations.Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinicComparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal acute myeloid leukemia (CN-AML) and FLT3ITD.VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myelomaAn update on drug combinations for treatment of myeloma.Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical use.FMS-related tyrosine kinase 3 internal tandem duplication (FLT3-ITD): a villain among others.Molecular analysis of different FLT3-ITD mutations in acute myeloid leukemia.Refining the prognostic importance of the diversity of FLT3 internal tandem duplications.Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort.The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients.Clonal heterogeneity of -ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemia
P2860
Q28289859-0CEB9986-78CC-47AF-94BF-4303B5E4F495Q34095013-C5D3851C-724A-45E4-A420-6EEF7D9AE3C8Q34229555-9DB71BFE-89BB-40C5-BF57-1B108BABE92DQ34775475-B8DCD5AF-7AF4-4959-8A99-403F8C6BF718Q34817365-BB0BB58A-B651-4FD9-B8A4-A042F91B1B94Q36390379-CA6FD98D-43B4-4E75-B9DC-E78C975BE36DQ36878944-59F08476-F32D-48AE-A8E8-25E0ED306483Q37038973-2588269D-4B89-454C-BFD2-04F168491099Q38183943-A895AE51-C7EF-4FEC-86A5-55FEA74B1469Q42349214-2CF74D46-48A3-4220-8B09-E181A3AC0890Q45024752-D12FE1C4-8107-40E4-84A4-28896359B2ACQ46122144-52D05ECA-72DB-447D-A2F5-E4CC14D74348Q46576832-1447C79E-C462-41F5-BBC3-7CAAE7A55D79Q47320656-E5F6EEAE-A9E5-479C-9228-9B65CE6B91D7Q56968572-F09C16FF-CC8A-49FB-9423-1BE2B6BE0F3A
P2860
More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML).
@en
More on prognostic significance of FLT3/ITD size in acute myeloid leukemia
@nl
type
label
More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML).
@en
More on prognostic significance of FLT3/ITD size in acute myeloid leukemia
@nl
prefLabel
More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML).
@en
More on prognostic significance of FLT3/ITD size in acute myeloid leukemia
@nl
P2093
P1433
P1476
More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML).
@en
P2093
Branimir Jaksic
Ozren Jaksic
Radovan Vrhovac
Rajko Kusec
Slobodanka Ostojic
P304
405-6; author reply 406
P356
10.1182/BLOOD-2005-12-5128
P407
P577
2006-07-01T00:00:00Z